Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 12.

Andergassen, U., Rack, B., Annecke, K., Forstbauer, H., Ruhland, F., Harbeck, N., Sommer, H., Friese, K., Janni, W. and Kiechle, M. (2010). Tumor Characteristics and Prognostic Factors in Nodal Positive Early Stage Breast Cancer of Obese Patients - Sub Analysis of the German ADEBAR Study. Cancer Res., 70. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Berling-Ernst, A., Yahiaoui-Doktor, M., Kiechle, M., Engel, C., Lammert, J., Grill, S., Dukatz, R., Rhiem, K., Baumann, F. T., Bischoff, S. C., Erickson, N., Schmidt, T., Niederberger, U., Siniatchkin, M. and Halle, M. (2022). Predictors of cardiopulmonary fitness in cancer-affected and -unaffected women with a pathogenic germline variant in the genes BRCA1/2 (LIBRE-1). Sci Rep, 12 (1). BERLIN: NATURE PORTFOLIO. ISSN 2045-2322

Bosse, Autoren K., Faust, U., Gruber, I, Habhab, W., Guenther, G., Siebers-Renelt, U., Kiechle, M., Speiser, D., Dikow, N., Kast, K., Arnold, N., Vesper, A-S, Harbeck, N., Briest, S., Thomssen, C., Gehrig, A., Wallaschek, H., Solbach, C., Wolf, M., Witzel, I, Holzhauser, I, Kaulfuss, S., Janni, W., Engel, C., Riess, O., Schmutzler, R. and Schroeder, C. (2020). Clinical-pathological Characterization of 1078 Advice Seekers with pathogenic CHEK2 Mutation from the German Consortium of Familial Breast and Ovarian Cancer (DK-FBREK). Geburtshilfe Frauenheilkd., 80 (6). S. E23 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804

Dukatz, R., Halle, M., Engel, C., Berling, A., Hebestreit, K., Bischoff, S., Pfeifer, K., Grill, S., Yahiaoui-Doktor, M., Enders, U., Siniatchkin, M., Gerber, D., Bridstrup, J., Erickson, N., Loeffler, M., Meindl, A., Rhiem, K., Schmutzler, R. and Kiechle, M. (2016). Feasibility assessment on a lifestyle intervention in healthy and diseased BRCA 1/2 mutation carriers. Oncol. Res. Treat., 39. S. 59 - 60. BASEL: KARGER. ISSN 2296-5262

Emons, G., Schmutzler, R. and Kiechle, M. (2020). 150th Birthday of the Archives of Gynecology and Obstetrics. Gynakologe, 53 (11). S. 725 - 726. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0393

Habhab, W., Faust, U., Guenther, G., Siebers-Renelt, U., Kiechle, M., Ott, C., Dikow, N., Kast, K., Vesper, A., Solbach, C., Harbeck, N., Stiller, M., Gehrig, A., Thomssen, C., Wallaschek, H., Arnold, N., Holzhauser, I., Kaulfuss, S., Volk, A., Janni, W., Engel, C., Schmutzler, R., Riess, O., Schroeder, C. and Bosse, K. (2020). Clinical and molecular characterization of 1253 carriers of a deleterious CHEK2 mutation from the German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC). Eur. J. Hum. Genet., 28 (SUPPL 1). S. 93 - 95. LONDON: SPRINGERNATURE. ISSN 1476-5438

Hepp, P. G. M., Rack, B., Annecke, K., Wischnik, A., Wolfgang, S., Zwingers, T., Harbeck, N., Sommer, H. L., Friese, K., Kiechle, M. and Janni, W. (2010). Multivariate Analysis of Obesity and Disease Free Survival in Patients with Nodal Positive Primary Breast Cancer - The ADEBAR Trial. Cancer Res., 70. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Janni, W. J., Harbeck, N., Sommer, H., Rack, B., Salmen, J., Augustin, D., Simon, W., Jueckstock, J., Wischnik, A., Anneke, K., Melcher, C., Friese, K. and Kiechle, M. (2011). Sequential Treatment with Epirubicin/Cyclophosphamide, Followed by Docetaxel vs. FEC120 in the Adjuvant Treatment of Breast Cancer Patients with Extensive Lymph Node Involvement: Final Survival Analysis of the German ADEBAR Phase Ill Study. Cancer Res., 71. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Rhiem, K., Bick, U., Kast, K., Niederacher, D., Solbach, C., Emons, G., Witzel, I., Brigitte, S., Bartram, C., Maass, N., Lemke, J., Kiechle, M., Mahner, S., Wieacker, P., Ortmann, O., Riess, O., Janni, W., Haaf, T. and Schmutzler, R. K. (2018). New structures of the German Consortium for Hereditary Breast and Ovarian Cancer. Oncol. Res. Treat., 41. S. 183 - 184. BASEL: KARGER. ISSN 2296-5262

Rhiem, K., Schott, S., Tio, J., Speiser, D., Briest, S., Vesper, A. -S., Kast, K., Kiechle, M., Wockel, A., Mundhenke, C., Ditsch, N., Janni, W., Seitz, S. and Schmutzler, R. K. (2018). Results of intensified breast cancer Screening in women after Radiation for Hodgkin's lymphoma in childhood and adolescence. Oncol. Res. Treat., 41. S. 7 - 8. BASEL: KARGER. ISSN 2296-5262

Richters, L., Rhiem, K., Wappenschmidt, B., Kiechle, M. and Schmutzler, R. (2014). Pathological complete response rates in patients with BRCA1/2-associated breast cancer after neoadjuvant chemotherapy. Oncol. Res. Treat., 37. S. 13 - 15. BASEL: KARGER. ISSN 2296-5262

Waha, A., Versmold, B., Kast, K., Kiechle, M., Ditsch, N., Meindl, A., Niederacher, D., Hahnen, E., Arnold, N., Mundhenke, C., Horvath, J., Bernd, A., Dikow, N., Hauke, J., Wappenschmidt, B., Riess, O., Schott, S., Speiser, D., Faust, U., Sutter, C., Rhiem, K. and Schmutzler, R. K. (2018). Consensus recommendation of the German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC) on the transfer of multigene analysis data into the clinical care program. Oncol. Res. Treat., 41. S. 182 - 183. BASEL: KARGER. ISSN 2296-5262

This list was generated on Thu Mar 28 14:16:17 2024 CET.